Search Results

Keywords: "United Kingdom"

Report: $5.5 billion up for grabs if Australia legalizes cannabis

October 26, 2018 · Updated November 15, 2021

A new report pegs Australia’s recreational cannabis market at 7.8 billion Australian dollars ($5.5 billion) – assuming a fully legal and regulated market is put in place by 2023. In neighboring New Zealand, commercial opportunities from a fully regulated recreational marijuana industry would top 977 million New Zealand dollars ($634 million), the report from United […]

Read More

Former PM Mulroney: ‘Others will follow’ Canada’s lead on cannabis

October 19, 2018

Former Prime Minister Brian Mulroney says other countries will follow Canada’s lead on cannabis legalization, but it will take time. On the same day Canada legalized marijuana for recreational use, Mulroney announced his intention to join the board of Acreage Holdings – one of the largest marijuana companies in the United States. Mulroney – prime […]

Read More

Lithuania becomes Europe’s latest adopter of medical marijuana

October 19, 2018

Lithuania’s Parliament voted unanimously to give doctors the ability to prescribe marijuana to treat certain health conditions, making it the latest European Union country to approve the use of medical cannabis. Agence France-Presse reported that the pending law will come into force May 1, and the sale of medical marijuana will require a license from […]

Read More

Is Canada’s marijuana legalization a ‘template’ for the world to follow?

October 17, 2018 · Updated November 12, 2020

Canada took its first steps into a future of legal cannabis Wednesday, but what that means for prohibition in other countries largely remains to be seen. Will other countries follow Canada’s move toward ending prohibition? What impact will ending prohibition there have on global medical cannabis markets? Canadian Senator Tony Dean believes every country will […]

Read More

Ahead of Canada’s big day, forecast for cannabis industry gets a boost

October 16, 2018 · Updated August 15, 2019

On the eve of Canada’s historic launch of its recreational marijuana program, the global cannabis industry appears poised for explosive growth thanks to the confluence of a host of market developments. “The well-capitalized cannabis industry has been evolving rapidly and looks to address a far larger (market) than we had originally forecast,” Wall Street analyst […]

Read More

CBD drugmaker GW Pharmaceuticals poised to raise $300 million

October 2, 2018 · Updated August 15, 2019

GW Pharmaceuticals is setting out to sell $300 million worth of U.S. depository shares. The London-based company’s announcement comes on the heels of the U.S. Drug Enforcement Administration’s move to take some cannabidiol products off the most restrictive class of controlled substances. That change will allow Epidiolex – a CBD drug manufactured by GW Pharmaceuticals to treat rare […]

Read More

Infused Business Strategies: Seeing Green

October 1, 2018 · Updated June 6, 2021

Sophisticated manufacturing, strategic product development and pricing, and vertical integration are keys to Green Gorilla’s success in the CBD market Type CBD into a search engine and it will populate with new brand names every day, said Steve DeForest, the chief operating officer and chief compliance officer for Los Angeles-based Green Gorilla, a manufacturer and […]

Read More

DEA moves some CBD medicines off Schedule 1, a limited expansion of cannabis access

September 27, 2018 · Updated May 20, 2019

The U.S. Drug Enforcement Administration has taken some cannabidiol off the most restrictive class of controlled substances, a move that allows the sale of the first nonsynthetic, cannabis-derived medicine to win federal approval.

It’s a decision that immediately affects CBD producers but also signals the agency’s first admission that the plant has medical value.

Read More

UK to rely on imports to meet ‘unlicensed’ medical cannabis demand

September 13, 2018

The United Kingdom likely will lean on imports to supply “unlicensed” cannabis-derived products after medical marijuana becomes available by prescription later this year. A new report by a council studying medical cannabis in the U.K. advises the government should encourage pharmaceutical companies to apply to the Healthcare Products Regulatory Agency for a license to market cannabis-derived medicinal […]

Read More

Marlboro maker ‘evaluating opportunities’ in cannabis industry

September 5, 2018 · Updated October 22, 2018

Altria Group, one of the largest tobacco companies in North America, is assessing its market opportunities in the cannabis industry. The entry of Altria – owner of Marlboro maker Philip Morris USA and an investor in alcohol giant Anheuser-Busch InBev – would be another major milestone for the marijuana sector, coming on the heels of […]

Read More

Marijuana exchange-traded fund takes in $22 million in August

August 31, 2018

Investors are flocking to a U.S.-listed exchange-traded fund (ETF) that tracks nearly 40 Canadian and American cannabis firms. The $436 million ETFMG Alternative Harvest ETF – which trades on the NYSE Arca under the ticker symbol MJ – has taken in around $22 million in August, putting it in a position to post its largest monthly inflow […]

Read More